SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is surging following overwhelmingly positive Phase 2 S-OLARIS trial results for sonelokimab in axial spondyloarthritis, which showcased an 81% ASAS40 response rate and early signs of disease modification. The community is buzzing with extreme bullishness, citing these best-in-class results, robust financials, and anticipated short-covering as key drivers ahead of a highly awaited Investor Day.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending due to prevailing community bearishness surrounding new global tariffs and escalating geopolitical tensions, which, coupled with a crypto market downturn, has many anticipating a notable market correction.

TOSHI

TOSHI is actively trending across the crypto community, driven by strong technical indicators pointing to an imminent breakout and a prevailing bullish sentiment for its role as a key memecoin within the Base ecosystem. Many investors are seizing current price levels, anticipating a substantial rally as altcoin season gains momentum.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

ProShares Short Bitcoin Strategy ETF ($BITI) is trending as community discussion links Jeffrey Epstein to early Bitcoin development, sparking strong bearish sentiment. Many traders are actively shorting Bitcoin, labeling it a 'pedo-currency' and expecting significant price drops.

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

Figure Technology Solutions faces intense scrutiny and a sharp price decline, attributed by some to a major bank's downgrade and "pump and dump" concerns; meanwhile, a bullish segment of the community views the current dip as a generational buying opportunity for its blockchain-native lending platform ahead of expected strong earnings.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to a recent filing that would allow Trump's trust to sell a significant amount of stock and includes an evergreen provision for future share issuance, sparking active community discussion and widespread concerns over potential dilution and the company's long-term valuation.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining is trending as investors react to its record financial results and the impending completion of its transformative acquisition of New Gold. The community is actively discussing the combined entity's increased production and significant operational leverage from rising gold and silver prices, anticipating substantial upside and potential short interest action.

Pump.fun

Pump.fun (PUMP CRYPTO) is experiencing significant market conversation after news broke of a former developer's fraud sentencing and an intensifying lawsuit, fueling both strong calls to "pump it" by loyalists citing platform buybacks, and concerns about its legitimacy among skeptics.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is seeing significant conversation after a leadership change brought co-founder Aneel Bhusri back as CEO to spearhead its AI transformation, with recent earnings guidance and AI acquisitions sparking intense community debate over its growth prospects in a rapidly evolving SaaS landscape.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following pivotal international approvals for ANKTIVA in Europe and Saudi Arabia, positioning it as a global oncology platform, while elevated short interest has the community anticipating a significant squeeze amidst expanding commercialization and pipeline catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALLE Allegion reports Q4 adjusted EPS $1.94, consensus $1.98 
 
Reports Q4 revenue $1.03B, consensus $1.04B. &quot;I&#39;m proud of the Allegion team as we delivered on our commitments to customers and shareholders, finishing out a strong 2025 marked by high-single digit enterprise revenue growth, accretive capital deployment and strong cash generation,&quot; Allegion President and CEO John Stone said. &quot;As we enter 2026, we see continued growth led by Americas non-residential and will remain agile as we execute our strategy.&quot;

Karen Valentine

Jasper Blackthorn

Aaron Northman

StockTwits Web

Allegion plc

 Allegion reports Q4 adjusted EPS $1.94, consensus $1.98 
 
Reports Q4 revenue $1.03B, consensus $1.04B. "I'm proud of the Allegion team as we delivered on our commitments to customers and shareholders, finishing out a strong 2025 marked by high-single digit enterprise revenue growth, accretive capital deployment and strong cash generation," Allegion President and CEO John Stone said. "As we enter 2026, we see continued growth led by Americas non-residential and will remain agile as we execute our strategy."